Evidence map›Paper›PMID 29930941›Full record

ArticleFrontiers in surgery2018

Favoring D

Ioannis Karavokyros, Adamantios Michalinos

Open access · goldAbstract read
In one paragraph

Article in Frontiers in surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Current management of gastric adenocarcinoma: a narrative review.Journal of gastrointestinal oncology · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. A study of outcomes, technical safety, and feasibility of D-2 lymphadenectomy in gastric cancer.JGH open : an open access journal of gastroenterology and hepatology · 2020
    Article
  10. Article
  11. Overexpression of CrkL as a novel biomarker for poor prognosis in gastric cancer.Cancer biomarkers : section A of Disease markers · 2019
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ioannis KaravokyrosFirst Department of Surgery, National and Kapodistrian University of Athens, Athens, Greece.
Adamantios MichalinosFirst Department of Surgery, National and Kapodistrian University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of extended lymphadenectomy in the surgical treatment of gastric cancer has been debated for many years. So far six prospective randomized trials and a number of meta-analyses comparing D

Indexed as

D2-dissectionD2-lymphadenectomyextended lymphadenectomygastrectomygastric cancerlymphadenectomyradical lymphadenectomy

Identifiers

PMID29930941
PMCPMC6001702
OpenAlexW2802170322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.